Clinical Trial Update: Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons [NA]

View source ↗

Summary

Clinical trial update notes the completion of a study evaluating isoniazid plus antiretroviral therapy to prevent tuberculosis in HIV-infected persons.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• Antiretroviral therapy
• ISONIAZID (ISONIAZID)

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculosis, Latent Tuberculosis Infection | NA | Status: COMPLETED